TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia)
about
The evolution of poxvirus vaccinesCytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasisCytokine responses to novel antigens in an Indian population living in an area endemic for visceral leishmaniasisA Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes.Cytokine responses to novel antigens in a peri-urban population in Brazil exposed to Leishmania infantum chagasi.Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection.Prediction of CD8+ Epitopes in Leishmania braziliensis Proteins Using EPIBOT: In Silico Search and In Vivo Validation.Coinjection with TLR2 agonist Pam3CSK4 reduces the pathology of leishmanization in mice.Proteins of Leishmania (Viannia) shawi confer protection associated with Th1 immune response and memory generation.A Common Genetic Variant in TLR1 Enhances Human Neutrophil Priming and Impacts Length of Intensive Care Stay in Pediatric Sepsis.HIV-specific CD8⁺ T cells and HIV eradicationThe TLR2/6 ligand PAM2CSK4 is a Th2 polarizing adjuvant in Leishmania major and Brugia malayi murine vaccine models.CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFNγ(+)-mediated parasite killing in human cutaneous leishmaniasisRegulatory actions of Toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liver.Toll-like receptors in leishmania infections: guardians or promoters?Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases.CD8+ T cells in cutaneous leishmaniasis: the good, the bad, and the ugly.Distinct Roles of Th17 and Th1 Cells in Inflammatory Responses Associated with the Presentation of Paucibacillary Leprosy and Leprosy Reactions.CD8+ T Cells Lack Local Signals To Produce IFN-γ in the Skin during Leishmania Infection.Leishmania Hijacks Myeloid Cells for Immune Escape.
P2860
Q26995905-2ED9C27D-F9BD-4518-9C7F-A9698CAD7489Q27334358-D049D253-B3E7-4C05-9B3F-ECADFA47D108Q28485121-D255CD59-C412-4798-976C-F77853AFD9FEQ30385378-195AE2E7-A704-4014-9E04-1ACBD4901876Q30416865-6B59E2ED-5681-4093-883A-58C57653185AQ35098224-C22402FA-C18C-47AC-80D4-12BA4639AB64Q35532615-FE01569D-E2D0-4271-A663-ECC3F759756AQ35571431-2BDACC95-DF62-4D50-B188-BABA3FB844E2Q35927732-91219A87-D60D-49A0-B394-15B664DF7C10Q36495095-98FA255D-D9FC-47E7-BFB8-E596D92700F1Q36515071-378F0D0D-7840-4B4D-891F-57459A2C75F5Q36599857-58EE2CE2-99F0-4387-A96F-6F6EA81C6488Q36886086-17DEED37-B7D6-47F5-A512-92EE9DAB468FQ36970905-D8CB0F3B-5F61-445A-A362-0C3582614301Q38004493-00AA33ED-5D5D-4037-BDCF-CE7C26E043E2Q38342834-BF542756-7CF8-4CDA-A6F4-B8CF634940EDQ38387770-7E66B203-3B3F-4359-9F1F-28BD3B4FD132Q40244169-01B9E794-9B2A-496A-B4A3-3FC5F2346E81Q48172873-A89880F9-2537-4779-80B3-8545BA3024B1Q55043523-6F28D965-8524-4951-971E-EA5211DE9C91
P2860
TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia)
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
TLR1/2 activation during heter ...... n against Leishmania (Viannia)
@ast
TLR1/2 activation during heter ...... n against Leishmania (Viannia)
@en
type
label
TLR1/2 activation during heter ...... n against Leishmania (Viannia)
@ast
TLR1/2 activation during heter ...... n against Leishmania (Viannia)
@en
prefLabel
TLR1/2 activation during heter ...... n against Leishmania (Viannia)
@ast
TLR1/2 activation during heter ...... n against Leishmania (Viannia)
@en
P2093
P2860
P1476
TLR1/2 activation during heter ...... n against Leishmania (Viannia)
@en
P2093
Asha Jayakumar
Diane McMahon-Pratt
Esther Park
Jenefer M Blackwell
Karen Goldsmith-Pestana
P2860
P356
10.1371/JOURNAL.PNTD.0001204
P407
P577
2011-06-14T00:00:00Z